Neurotransmitter Pathways Anatomy
On this page
Direct answer
A handful of small brainstem and diencephalic cell groups project to the entire neuraxis, and each projection system carries a disease with it. Dopaminergic neurons of the substantia nigra pars compacta (A9) run the nigrostriatal pathway lost in Parkinson disease; the ventral tegmental area (A10) supplies the mesolimbic and mesocortical pathways implicated in reward and schizophrenia; the arcuate tuberoinfundibular pathway delivers dopamine as prolactin-inhibiting factor to the pituitary portal system. The cholinergic nucleus basalis of Meynert degenerates in Alzheimer disease, the noradrenergic locus coeruleus governs arousal and the stress response, the serotonergic raphe nuclei modulate mood, sleep and descending pain control, and the histaminergic tuberomammillary nucleus of the hypothalamus sustains wakefulness. Knowing the anatomy of these systems converts psychiatric pharmacology from memorisation into logic.
What you must remember
- Nigrostriatal pathway: substantia nigra pars compacta (A9) to striatum; symptoms of Parkinson disease appear after roughly 80 per cent of the dopamine is gone — bradykinesia, rigidity, 4-6 Hz pill-rolling resting tremor, Lewy bodies.
- Mesolimbic pathway: ventral tegmental area (A10) to nucleus accumbens, amygdala and hippocampus — reward, addiction and the positive symptoms of schizophrenia; amphetamine and psychosis share this anatomy.
- Mesocortical pathway: ventral tegmental area to prefrontal cortex — negative and cognitive symptoms improve when this arm is spared by antipsychotics.
- Tuberoinfundibular pathway: arcuate nucleus to the median eminence portal system; dopamine is prolactin-inhibiting factor, so D2 blockade causes hyperprolactinaemia — galactorrhoea, amenorrhoea, infertility.
- Nucleus basalis of Meynert: cholinergic neurons to the entire cortex, devastated in Alzheimer disease — the rationale for cholinesterase inhibitors; the pedunculopontine nucleus drives REM sleep and startle.
- Locus coeruleus: noradrenergic "blue spot" in the floor of the upper fourth ventricle; projects everywhere for arousal, attention, panic and opioid withdrawal; clonidine tames withdrawal by alpha-2 agonism.
- Raphe nuclei: serotonergic midline band from medulla to midbrain — mood, sleep-wake cycling, and descending pain inhibition (the target of SSRIs and of triptan-SSRI serotonin syndrome).
- Tuberomammillary nucleus: the brain's only histaminergic population, in the posterior hypothalamus — the sedation of first-generation antihistamines is this nucleus silenced.
Why antipsychotics cause galactorrhoea but levodopa does not
Follow the anatomy. Risperidone blocks D2 receptors wherever they are dense, including the tuberoinfundibular terminals in the median eminence; with prolactin-inhibiting dopamine silenced at the portal plexus, lactotrophs escape inhibition and prolactin climbs — the young woman on risperidone develops galactorrhoea and amenorrhoea. Levodopa, by contrast, is taken up by the remaining nigrostriatal terminals and restored neurons; it raises dopamine in the striatum where it is needed, and the pituitary lactotrophs see little change. One drug distributes through the whole brain by receptor blockade, the other supplements a specific degenerating pathway — the clinical difference is pure pathway anatomy.
The same logic organises psychiatry: clozapine's weak tuberoinfundibular blockade spares prolactin; its mesolimbic preference spares the nigrostriatal system, so parkinsonism is rare. In neurology, the loss of A9 neurons with relative sparing of A10 explains why early Parkinson disease moves poorly but feels and rewards normally, until later disease involves mesocortical arms and apathy emerges.
Where students slip
Two reversals recur: assigning the mesolimbic pathway to the substantia nigra (it belongs to the ventral tegmental area) and the prolactin effect to the nigrostriatal system (it belongs to the tuberoinfundibular). Students also place the nucleus basalis in the midbrain — it lies in the basal forebrain, below the anterior commissure, degenerating with cortical cholinergic markers in Alzheimer disease. A final trap is calling the locus coeruleus serotonergic; it is noradrenergic, and the raphe nuclei are the serotonergic ones. In Indian vivas the standard framing is "name the dopaminergic pathways with one clinical correlate each" — deliver nigrostriatal, mesolimbic, mesocortical and tuberoinfundibular in that order, then close with Meynert for Alzheimer disease.
Frequently asked questions
Which dopaminergic pathway controls prolactin secretion?
The tuberoinfundibular pathway from the arcuate nucleus to the hypophyseal portal system. Dopamine is prolactin-inhibiting factor, so its blockade causes hyperprolactinaemia.
Which cholinergic nucleus degenerates in Alzheimer disease?
The nucleus basalis of Meynert in the basal forebrain, which cholinergically supplies the cortex. Cholinesterase inhibitors aim to amplify what remains.
What is the locus coeruleus and what does it release?
A noradrenergic nucleus in the floor of the upper fourth ventricle, projecting to nearly the whole neuraxis. It drives arousal, attention and the stress response.
Which pathway is implicated in the positive symptoms of schizophrenia?
The mesolimbic pathway from the ventral tegmental area (A10) to the nucleus accumbens. D2 blockade there relieves positive symptoms.
Where are the brain's histaminergic neurons?
In the tuberomammillary nucleus of the posterior hypothalamus. Their blockade explains the drowsiness of classical antihistamines.